Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/17/2027 | CALL | $190.00 | 19 | +16 | +533.33% |
| 06/17/2027 | PUT | $140.00 | 15 | +15 | |
| 03/20/2026 | PUT | $185.00 | 88 | +12 | +15.79% |
| 03/20/2026 | PUT | $180.00 | 18 | +10 | +125.00% |
| 03/20/2026 | PUT | $190.00 | 71 | +8 | +12.70% |
| 01/21/2028 | CALL | $110.00 | 266 | +8 | +3.10% |
| 04/17/2026 | PUT | $97.50 | 56 | -9 | -13.85% |
| 03/20/2026 | PUT | $110.00 | 5 | -15 | -75.00% |
| 04/17/2026 | PUT | $87.50 | 473 | -19 | -3.86% |
| 04/17/2026 | PUT | $230.00 | 2 | -23 | -92.00% |
| 03/20/2026 | PUT | $115.00 | 0 | -68 | -100.00% |
| 04/17/2026 | PUT | $115.00 | 2 | -89 | -97.80% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Washington Mutual Investors Fund | 1.04% | 27.18M | 1.81B |
| Vanguard/Primecap Fund | 0.99% | 25.87M | 1.72B |
| Vanguard/Wellington Fund Inc. | 0.73% | 19.18M | 1.28B |
| American Mutual Fund Inc | 0.33% | 8.7M | 578.3M |
| Price (T.Rowe) Health Sciences Fund | 0.30% | 8M | 531.71M |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 0.30% | 7.93M | 526.89M |
| Vanguard Fenway Funds-Equity Income Fund | 0.27% | 7.11M | 472.77M |
| Price (T.Rowe) Value Fund | 0.22% | 5.86M | 389.5M |
| Vanguard Fenway Fds-Primecap Core Fund | 0.21% | 5.63M | 374.17M |
| Vanguard/Wellesley Income Fund | 0.20% | 5.28M | 351.09M |
GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026
03/05 11:58 am
GlobeNewswire Inc.
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreCDT Positions for Transformational Growth
03/04 09:30 am
Benzinga
Read moreGLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - Clinical Trials Exploring GLP-1 Role in NAFLD and NASH Unlock Future Opportunities
03/04 06:48 am
GlobeNewswire Inc.
Read moreAcute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight
03/02 02:00 pm
GlobeNewswire Inc.
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read morePatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
02/26 02:35 pm
GlobeNewswire Inc.
Read moreFDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer
02/20 09:02 am
Benzinga
Read moreGlucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - Oral Formulations and Long-Acting Peptides Accelerate Next-Gen Obesity and Diabetes Therapies
02/20 06:53 am
GlobeNewswire Inc.
Read moreCTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
02/18 12:00 pm
GlobeNewswire Inc.
Read moreTurner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider
02/18 06:55 am
GlobeNewswire Inc.
Read moreUterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider
02/16 09:00 am
GlobeNewswire Inc.
Read moreNIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED)
02/12 03:55 pm
Benzinga
Read moreAstraZeneca Cancer Portfolio Dominates Sales With Massive Double Digit Growth
02/10 01:32 pm
Benzinga
Read moreAnti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management
02/06 06:00 am
GlobeNewswire Inc.
Read moreThis Global ETF Could Help Protect You From the "Sell America" Trade
02/05 06:07 am
The Motley Fool
Read moreObesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally
02/05 05:00 am
GlobeNewswire Inc.
Read moreHuman Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider
02/05 04:57 am
GlobeNewswire Inc.
Read moreAstraZeneca Responds With Data After FDA Delays Lupus Drug Shot
02/03 07:55 am
Benzinga
Read moreTargeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
02/03 02:56 am
GlobeNewswire Inc.
Read moreAstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration
01/30 08:09 am
Benzinga
Read moreAstraZeneca Bets Big On China With Massive $15 Billion Investment
01/29 12:51 pm
Benzinga
Read moreAtopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR
01/27 11:00 am
GlobeNewswire Inc.
Read moreLooking for Growth Opportunities Outside the U.S. Market? This International ETF Soared Past the S&P 500 Last Year
01/23 08:32 am
The Motley Fool
Read moreIs This Dividend King Stock a Buy After a Major Development?
01/21 10:30 pm
The Motley Fool
Read moreHigh Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
01/21 12:00 pm
GlobeNewswire Inc.
Read moreAstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach
01/20 12:47 pm
Benzinga
Read moreBioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider
01/19 12:00 pm
GlobeNewswire Inc.
Read moreAbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
01/18 08:30 pm
Benzinga
Read moreThe Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company)
01/15 04:02 am
The Motley Fool
Read moreAscentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
01/14 09:25 pm
GlobeNewswire Inc.
Read moreGeneralized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight
01/14 02:00 pm
GlobeNewswire Inc.
Read moreHUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
01/14 12:00 am
GlobeNewswire Inc.
Read more1 Quantum Computing Stock to Buy that Could Soar in 2026
01/13 03:16 pm
The Motley Fool
Read moreSystemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
01/13 02:00 pm
GlobeNewswire Inc.
Read morePharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor
01/08 05:30 pm
Benzinga
Read moreAstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial
01/06 07:43 am
Benzinga
Read moreG-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider
01/05 11:00 am
GlobeNewswire Inc.
Read moreInvest Outside the U.S. With These Top International ETFs
12/31 03:20 pm
The Motley Fool
Read moreAstraZeneca's Lung Cancer Combo Falls Short In Phase 3 Trial
12/22 01:19 pm
Benzinga
Read moreGSK Expands Use Of Urinary Tract Infection Drug For Gonorrhoea Patients
12/12 12:12 pm
Benzinga
Read moreGestational Diabetes Market to Reach USD 22.58 Billion by 2034, Driven by Rising Awareness and Rapid Innovations
12/11 11:00 am
GlobeNewswire Inc.
Read moreDrugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks
12/09 12:30 pm
Benzinga
Read moreAstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report
12/03 01:24 pm
Benzinga
Read moreAstraZeneca's Hard To Control Hypertension Drug Advances, With FDA Decision Expected In 2026
12/03 11:27 am
Benzinga
Read moreSeasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035
12/03 11:00 am
GlobeNewswire Inc.
Read moreVaccine Development Company Landscape Report 2025: Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis
12/02 05:37 am
GlobeNewswire Inc.
Read moreGeriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®
11/27 11:50 pm
GlobeNewswire Inc.
Read moreHER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight
11/27 02:00 pm
GlobeNewswire Inc.
Read more